166 related articles for article (PubMed ID: 9362053)
1. Plasma thymidine kinase activity in dogs with lymphoma and leukemia.
Nakamura N; Momoi Y; Watari T; Yoshino T; Tsujimoto H; Hasegawa A
J Vet Med Sci; 1997 Oct; 59(10):957-60. PubMed ID: 9362053
[TBL] [Abstract][Full Text] [Related]
2. Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease.
von Euler H; Einarsson R; Olsson U; Lagerstedt AS; Eriksson S
J Vet Intern Med; 2004; 18(5):696-702. PubMed ID: 15515587
[TBL] [Abstract][Full Text] [Related]
3. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
von Euler HP; Ohrvik AB; Eriksson SK
Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
[TBL] [Abstract][Full Text] [Related]
4. A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma.
Sharif H; von Euler H; Westberg S; He E; Wang L; Eriksson S
Vet J; 2012 Oct; 194(1):40-7. PubMed ID: 22516918
[TBL] [Abstract][Full Text] [Related]
5. Thymidine kinase assay in canine lymphoma.
Elliott JW; Cripps P; Blackwood L
Vet Comp Oncol; 2013 Mar; 11(1):1-13. PubMed ID: 22236202
[TBL] [Abstract][Full Text] [Related]
6. Serum thymidine kinase activity as a useful marker for bovine leukosis.
Sakamoto L; Ohbayashi T; Matsumoto K; Kobayashi Y; Inokuma H
J Vet Diagn Invest; 2009 Nov; 21(6):871-4. PubMed ID: 19901293
[TBL] [Abstract][Full Text] [Related]
7. Serum thymidine kinase activity: an alternative to histologic markers of cellular proliferation in canine lymphoma.
Madewell BR
J Vet Intern Med; 2004; 18(5):595-6. PubMed ID: 15515571
[TBL] [Abstract][Full Text] [Related]
8. Serum thymidine kinase activity in clinically healthy and diseased horses: a potential marker for lymphoma.
Larsdotter S; Nostell K; von Euler H
Vet J; 2015 Aug; 205(2):313-6. PubMed ID: 25744802
[TBL] [Abstract][Full Text] [Related]
9. A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.
Jagarlamudi KK; Moreau L; Westberg S; Rönnberg H; Eriksson S
PLoS One; 2015; 10(9):e0137871. PubMed ID: 26366881
[TBL] [Abstract][Full Text] [Related]
10. Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity--evaluation of a new, fully automated non-radiometric assay.
Von Euler HP; Rivera P; Aronsson AC; Bengtsson C; Hansson LO; Eriksson SK
Int J Oncol; 2009 Feb; 34(2):505-10. PubMed ID: 19148486
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum thymidine kinase activity in canine splenic hemangiosarcoma*.
Thamm DH; Kamstock DA; Sharp CR; Johnson SI; Mazzaferro E; Herold LV; Barnes SM; Winkler K; Selting KA
Vet Comp Oncol; 2012 Dec; 10(4):292-302. PubMed ID: 22236280
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of canine lymphoma.
Altman NH; Squire RA
J Am Vet Med Assoc; 1970 Dec; 157(11):1676-80. PubMed ID: 5536741
[No Abstract] [Full Text] [Related]
13. Clinical usefulness of peripheral blood lymphocyte subsets in canine lymphoma.
Miniscalco B; Guglielmino R; Morello E; Tarducci A; Geuna M
Vet Res Commun; 2003 Sep; 27 Suppl 1():407-9. PubMed ID: 14535441
[No Abstract] [Full Text] [Related]
14. Lymphoid Neoplasia: Correlations Between Morphology and Flow Cytometry.
Rout ED; Avery PR
Vet Clin North Am Small Anim Pract; 2017 Jan; 47(1):53-70. PubMed ID: 27542692
[TBL] [Abstract][Full Text] [Related]
15. Serum thymidine kinase 1 and C-reactive protein as biomarkers for screening clinically healthy dogs for occult disease.
Selting KA; Sharp CR; Ringold R; Knouse J
Vet Comp Oncol; 2015 Dec; 13(4):373-84. PubMed ID: 23859156
[TBL] [Abstract][Full Text] [Related]
16. Thymidine Kinase Type 1 and C-Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer.
Selting KA; Ringold R; Husbands B; Pithua PO
J Vet Intern Med; 2016 Jul; 30(4):1159-66. PubMed ID: 27214230
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of serum thymidine kinase 1 activity as a biomarker for treatment effectiveness and prediction of relapse in dogs with non-Hodgkin lymphoma.
Boyé P; Floch F; Serres F; Geeraert K; Clerson P; Siomboing X; Bergqvist M; Sack G; Tierny D
J Vet Intern Med; 2019 Jul; 33(4):1728-1739. PubMed ID: 31129922
[TBL] [Abstract][Full Text] [Related]
18. Profiling of serum metabolites in canine lymphoma using gas chromatography mass spectrometry.
Tamai R; Furuya M; Hatoya S; Akiyoshi H; Yamamoto R; Komori Y; Yokoi S; Tani K; Hirano Y; Komori M; Takenaka S
J Vet Med Sci; 2014 Nov; 76(11):1513-8. PubMed ID: 25131950
[TBL] [Abstract][Full Text] [Related]
19. Utility of serum thymidine kinase activity measurements for cases of bovine leukosis with difficult clinical diagnoses.
Tawfeeq MM; Miura S; Horiuchi N; Kobayashi Y; Furuoka H; Inokuma H
J Vet Med Sci; 2013; 75(9):1167-72. PubMed ID: 23628971
[TBL] [Abstract][Full Text] [Related]
20. Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.
Jagarlamudi KK; Westberg S; Rönnberg H; Eriksson S
BMC Vet Res; 2014 Oct; 10():228. PubMed ID: 25293656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
